Line of business: BlueAlliance (Commercial)
The percentage of adolescents 13 years of age who had one dose of meningococcal vaccine, one tetanus, diphtheria toxoids and acellular pertussis (Tdap) vaccine, and have completed the human papillomavirus (HPV) vaccine series by their 13th birthday.
Adolescents who received all the following (each row) within the specified time frames (see notes section).
Compliance can be met with any of the listed criteria for each vaccine in the below table (i.e. patient received the vaccine or has a history of the vaccine causing anaphylaxis or encephalitis).
Vaccine | Doses | Combo vaccine or antigen | Anaphylaxis r/t vaccine | Encephalitis r/t vaccine | |
MCV | Meningococcal | 1 | X | X | |
Tdap | Tetanus, diphtheria toxoids and acellular pertussis | 1 | X | X | X |
HPV | Human papilloma virus | 2-3 | X | X |
The analysis of any medical coding question related to a measure is dependent on the measure’s technical specifications including the factual situations present related to the member, the practice, the professionals, and the medical services provided.
Should you have specific coding or other questions related to the measure, please send your questions to BlueAlliance@bcbsnd.com.
HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).